Cellectis S.A. (CLLS) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 13 recommend buying, 2 recommend holding, and 1 recommend selling.
The analyst consensus price target for CLLS is $6.00, representing a +46.7% upside from the current price of $4.09. Price targets range from a low of $4.00 to a high of $8.00.
